<?xml version="1.0" encoding="UTF-8"?>
<p>Several studies (49/1159; 4%) reported mother-to-child or vertical transmission of CHIKV and many investigated fetal outcomes in neonates infected 
 <italic>in utero</italic> or post partum; 
 <xref ref-type="supplementary-material" rid="pone.0207554.s009">S6 Table</xref>. Pregnant women and neonates were the study subjects in 34/49 (69%) studies, while 13/49 (27%) studies reported on neonates alone. The impact of congenital CHIKV infection in neonates was reported in 16/49 (33%) studies and 6/49 (12%) studies investigated pregnancy outcomes due to CHIKV infection [
 <xref rid="pone.0207554.ref005" ref-type="bibr">5</xref>, 
 <xref rid="pone.0207554.ref264" ref-type="bibr">264</xref>â€“
 <xref rid="pone.0207554.ref267" ref-type="bibr">267</xref>]. One article recommended close monitoring of viremic pregnant mothers in maternity units. The same study reported that 12% of newborns are symptomatic, with many neonates requiring prolonged or intensive care due to complications such as meningoencephalits and intravascular coagulation [
 <xref rid="pone.0207554.ref265" ref-type="bibr">265</xref>].
</p>
